0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover716.32%IV63.34%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier14DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.0780Delta0.0147Gamma9.09Leverage Ratio-0.0488Theta-0.0005Rho-0.71Eff Leverage0.0020Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$